中文别名: |
(4S,5S)-(2,2-二甲基-1,3-二氧戊环-4,5-二基)双(二苯基甲醇);(+)-4,5-双[羟基(二苯基)甲基]-2,2-二甲基-1,3-二氧戊环;(4R,5S)-2,2-二甲基-α,α,α`,α`-四苯基-1,3-二氧戊环-4,6-二甲醇;(4S,5S)-2,2-二甲基-α,α,α',α'-四苯基-1,3-二氧戊环-4,5-二甲醇;(+)-2,3-O-异亚丙基-1,1,4,4-四苯基-D-苏糖醇;(+)-4,5-双[羟基(二苯基)甲基]-2,2-二甲基-1,3-二氧烷;(+)-反式-α,α'-(2,2-二甲基-1,3-二氧戊环-4,5-二基)双(二苯基甲醇);(4S,5S)-2,2-二甲基--1,3-二氧戊环-4,5-二基)双(二苯基甲醇);(+)-反式-α,α′-(2,2-二甲基-1,3-二氧戊环-4,5-二基)双(二苯基甲醇);(4S,5S)-4,5-双(二苯基羟甲基)-2,2-二甲基二氧戊环 |
英文别名: |
(+)-4,5-Bis[hydroxy(diphenyl)methyl]-2,2-dimethyl-1,3-dioxolane;(2S,3S)-(-)-4,5-Bis(diphenylhydroxymethyl)-2,2-dimethyl-1,3-dioxolane;(4S,5S)-4,5-Bis(diphenylhydroxymethyl)-2,2-dimethyldioxolane;1,1,4,4-Tetraphenyl-2,3-O-isopropylidene-L-threitol;((4S,5S)-2,2-Dimethyl-1,3-dioxolane-4,5-diyl)bis(diphenylmethanol);(+)-Taddol;DIMETHY-1,3-DIOXOLANE-4,5-DIYL (2,2-);(+)-(4S,5S)-TADDOL;(+)-2,6-BIS[(4R)-4-(I-PROPYL)-2-OXAZOLIN-2-YL]PYRIDINE;(S)-iPr-PyBox;(S,S)-2,2'-(2,6-Pyridinediyl)bis(4-isopropyl-2-oxazoline);(S,S)-ip-pybox;(S,S)-Pri-Pybox;(S,S)-Pybox-i-Pr;(S,S)-TADDOL;?(+)-Taddol;[(S,S)-i-Pr-Pybox];2,6-bis((S)-4-isopropyl-4,5-dihydrooxazol-2-yl)pyridine;2,6-Bis[(4S)-(-)-isopropyl-2-oxazolin-2-yl]pyridine;(+)-trans-α,α'-(2,2-Dimethyl-1,3-dioxolane-4,5-diyl)bis(diphenylmethanol);(2S,3S)-2,3-O-Isopropylidene-1,1,4,4-tetraphenyl-1,2,3,4-butanetetrol;(+)-2,3-O-Isopropylidene-1,1,4,4-tetraphenyl-D-threitol;(4S,5S)-2,2-Dimethyl-alpha,alpha,alpha',alpha'-tetraphenyldioxolane-4,5-dimethanol;C31H30O4;[(4S,5S)-2,2-dimethyl-1,3-dioxolane-4,5-diyl]bis(diphenylmethanol);(4S,5S)-2,2-Dimethyl-lla pound inverted question marka pound inverted question marketraphenyldioxolane-4,5-dimethanol;(S,s) |